Company Overview of Boehringer Ingelheim Limited
Boehringer Ingelheim Limited is engaged in the research, development, and manufacture of prescription medicines, over-the-counter, and animal healthcare products in the United Kingdom. It focuses on various medical conditions, such as respiratory, cardiology, virology, central nervous system, and cerebrovascular. The company offers prescription medicines for the treatment of chronic obstructive pulmonary disease, heart attack, secondary stroke prevention and treatment, high blood pressure, thromboembolic disease, HIV/AIDS, Parkinson's disease, arthritis, and pain relief in cancer. It offers consumer healthcare products in the areas of constipation, antispasmodics, stool softeners, vitamins a...
Bracknell, RG12 8YS
Founded in 1955
Key Executives for Boehringer Ingelheim Limited
Finance & Administration Director
Senior Vice President of Global Biopharma Operations
Head of Established Markets
Compensation as of Fiscal Year 2014.
Boehringer Ingelheim Limited Key Developments
Boehringer Inelheim Presents at 2014 Russian Pharmaceutical Forum, Jun-17-2014 through Jun-19-2014
Jun 10 14
Boehringer Inelheim Presents at 2014 Russian Pharmaceutical Forum, Jun-17-2014 through Jun-19-2014. Venue: Corinthia Saint-Petersburu Hotel, 57 Nevskij Prospect, St. Petersburg, Russia. Presentation Date & Speakers: Jun-17-2014, Darya Parshina, Director, Strategic Marketing. Jun-19-2014, Darya Parshina, Director, Strategic Marketing.
Boehringer Ingelheim Limited Presents at DigiPharm & Mobile Pharma Europe, Oct-09-2013 12:45 PM
Oct 8 13
Boehringer Ingelheim Limited Presents at DigiPharm & Mobile Pharma Europe, Oct-09-2013 12:45 PM. Venue: The Tower Hotel, London, United Kingdom. Speakers: Hannah Gagen, Patient Engagement & External Affairs Manager, Murat Tanören, Marketing Manager.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|